The Greater Cannabis Company, Inc. (GCAN)

Market Cap	137.02K -62.2%
Revenue (ttm)	n/a
Net Income	-712.72K
EPS	-0.98
Shares Out	944.94K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	524
Average Volume	10,686
Open	0.2550
Previous Close	n/a
Day's Range	0.2480 - 0.2550
52-Week Range	0.0360 - 3.6000
Beta	0.55
RSI	51.48
Earnings Date	Apr 2, 2026

About GCAN

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: GCAN